1.
Curtis JR, Elewaut D, Chen S, Hojnik M, Naveh N, Anderson JK. Incidence of Inflammatory Bowel Disease Events in Adalimumab Clinical Trials Across Indications. J of Skin [Internet]. 2017Oct.27 [cited 2020Nov.24];1(3.1):s18. Available from: https://jofskin.org/index.php/skin/article/view/73